367 related articles for article (PubMed ID: 29521227)
1. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.
Lan B; Chai S; Wang P; Wang K
Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Surveillance by Cdc48/p97: MAD vs. Membrane Fusion.
Escobar-Henriques M; Anton V
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961852
[TBL] [Abstract][Full Text] [Related]
3. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
[TBL] [Abstract][Full Text] [Related]
4. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
Costantini S; Capone F; Polo A; Bagnara P; Budillon A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
[TBL] [Abstract][Full Text] [Related]
5. A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase.
Segura-Cabrera A; Tripathi R; Zhang X; Gui L; Chou TF; Komurov K
Sci Rep; 2017 Mar; 7():44912. PubMed ID: 28322292
[TBL] [Abstract][Full Text] [Related]
6. Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells.
Yang FC; Lin YH; Chen WH; Huang JY; Chang HY; Su SH; Wang HT; Chiang CY; Hsu PH; Tsai MD; Tan BC; Lee SC
J Biol Chem; 2013 Nov; 288(47):33861-33872. PubMed ID: 24129571
[TBL] [Abstract][Full Text] [Related]
7. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation.
Ballar P; Zhong Y; Nagahama M; Tagaya M; Shen Y; Fang S
J Biol Chem; 2007 Nov; 282(47):33908-14. PubMed ID: 17872946
[TBL] [Abstract][Full Text] [Related]
8. Regulation of ER-associated degradation via p97/VCP-interacting motif.
Ballar P; Fang S
Biochem Soc Trans; 2008 Oct; 36(Pt 5):818-22. PubMed ID: 18793143
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in p97/VCP/Cdc48 cellular functions.
Yamanaka K; Sasagawa Y; Ogura T
Biochim Biophys Acta; 2012 Jan; 1823(1):130-7. PubMed ID: 21781992
[TBL] [Abstract][Full Text] [Related]
10. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
[TBL] [Abstract][Full Text] [Related]
11. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.
Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF
Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933
[TBL] [Abstract][Full Text] [Related]
12. Create and preserve: proteostasis in development and aging is governed by Cdc48/p97/VCP.
Franz A; Ackermann L; Hoppe T
Biochim Biophys Acta; 2014 Jan; 1843(1):205-15. PubMed ID: 23583830
[TBL] [Abstract][Full Text] [Related]
13. VCP inhibitors induce endoplasmic reticulum stress, cause cell cycle arrest, trigger caspase-mediated cell death and synergistically kill ovarian cancer cells in combination with Salubrinal.
Bastola P; Neums L; Schoenen FJ; Chien J
Mol Oncol; 2016 Dec; 10(10):1559-1574. PubMed ID: 27729194
[TBL] [Abstract][Full Text] [Related]
14. Selenoprotein S-dependent Selenoprotein K Binding to p97(VCP) Protein Is Essential for Endoplasmic Reticulum-associated Degradation.
Lee JH; Park KJ; Jang JK; Jeon YH; Ko KY; Kwon JH; Lee SR; Kim IY
J Biol Chem; 2015 Dec; 290(50):29941-52. PubMed ID: 26504085
[TBL] [Abstract][Full Text] [Related]
15. Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis.
Anderson DJ; Le Moigne R; Djakovic S; Kumar B; Rice J; Wong S; Wang J; Yao B; Valle E; Kiss von Soly S; Madriaga A; Soriano F; Menon MK; Wu ZY; Kampmann M; Chen Y; Weissman JS; Aftab BT; Yakes FM; Shawver L; Zhou HJ; Wustrow D; Rolfe M
Cancer Cell; 2015 Nov; 28(5):653-665. PubMed ID: 26555175
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of the ATPase p97/VCP: From basic research to clinical applications.
Kilgas S; Ramadan K
Cell Chem Biol; 2023 Jan; 30(1):3-21. PubMed ID: 36640759
[TBL] [Abstract][Full Text] [Related]
17. The VCP/p97 and YOD1 Proteins Have Different Substrate-dependent Activities in Endoplasmic Reticulum-associated Degradation (ERAD).
Sasset L; Petris G; Cesaratto F; Burrone OR
J Biol Chem; 2015 Nov; 290(47):28175-28188. PubMed ID: 26463207
[TBL] [Abstract][Full Text] [Related]
18. Structure and functions of the chaperone-like p97/CDC48 in plants.
Bègue H; Jeandroz S; Blanchard C; Wendehenne D; Rosnoblet C
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3053-3060. PubMed ID: 27717811
[TBL] [Abstract][Full Text] [Related]
19. BRSK2 is a valosin-containing protein (VCP)-interacting protein that affects VCP functioning in endoplasmic reticulum-associated degradation.
Wang Y; Wan B; Zhou J; Li R; Yu L
Biotechnol Lett; 2013 Dec; 35(12):1983-9. PubMed ID: 23907667
[TBL] [Abstract][Full Text] [Related]
20. p97: An Emerging Target for Cancer, Neurodegenerative Diseases, and Viral Infections.
Huryn DM; Kornfilt DJP; Wipf P
J Med Chem; 2020 Mar; 63(5):1892-1907. PubMed ID: 31550150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
